Teyi Pharmaceutical Group Co Ltd (002728) — Financial Flexibility Index
Teyi Pharmaceutical Group Co Ltd (002728) has a Financial Flexibility Index of 0.16x as of December 2025. Free cash flow of CN¥76.63 Million (operating CF CN¥52.94 Million minus capex CN¥23.69 Million) represents 0% of total liabilities (CN¥472.69 Million). Check Teyi Pharmaceutical Group Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Teyi Pharmaceutical Group Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Teyi Pharmaceutical Group Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see Teyi Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Teyi Pharmaceutical Group Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Teyi Pharmaceutical Group Co Ltd. Explore Teyi Pharmaceutical Group Co Ltd (002728) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥324.43 Million | CN¥244.88 Million | CN¥472.69 Million | ▲ +379.6% |
| 2024 | 0.14x | CN¥91.01 Million | CN¥-22.55 Million | CN¥635.94 Million | ▼ -74.8% |
| 2023 | 0.57x | CN¥284.60 Million | CN¥198.56 Million | CN¥501.95 Million | ▲ +40.2% |
| 2022 | 0.40x | CN¥461.92 Million | CN¥371.66 Million | CN¥1.14 Billion | ▼ -11.2% |
| 2021 | 0.46x | CN¥366.39 Million | CN¥256.81 Million | CN¥804.51 Million | ▲ +107.2% |
| 2020 | 0.22x | CN¥258.40 Million | CN¥168.99 Million | CN¥1.18 Billion | ▼ -31.2% |
| 2019 | 0.32x | CN¥352.44 Million | CN¥221.64 Million | CN¥1.10 Billion | ▼ -10.3% |
| 2018 | 0.36x | CN¥340.41 Million | CN¥187.97 Million | CN¥956.39 Million | ▲ +119.7% |
| 2017 | 0.16x | CN¥143.59 Million | CN¥102.96 Million | CN¥886.14 Million | ▼ -57.3% |
| 2016 | 0.38x | CN¥272.15 Million | CN¥101.30 Million | CN¥716.61 Million | ▲ +77.2% |
| 2015 | 0.21x | CN¥170.11 Million | CN¥68.87 Million | CN¥793.78 Million | ▼ -77.1% |
| 2014 | 0.94x | CN¥84.33 Million | CN¥57.35 Million | CN¥89.96 Million | ▼ -19.4% |
| 2013 | 1.16x | CN¥120.28 Million | CN¥74.23 Million | CN¥103.40 Million | ▼ -12.5% |
| 2012 | 1.33x | CN¥136.70 Million | CN¥104.50 Million | CN¥102.88 Million | ▼ -1.1% |
| 2011 | 1.34x | CN¥77.53 Million | CN¥69.81 Million | CN¥57.71 Million | ▲ +119.2% |
| 2010 | 0.61x | CN¥50.21 Million | CN¥46.92 Million | CN¥81.92 Million | ▲ +101.2% |
| 2009 | 0.30x | CN¥26.34 Million | CN¥22.32 Million | CN¥86.47 Million | — |